Dr. Elizabeth Buchbinder from Dana-Farber Cancer Institute (DFCI) in Boston, USA, will discuss the power of immunotherapy through checkpoint inhibitors. Join us as Dr. Buchbinder explores the latest advancements in immunotherapy and the transformative potential of checkpoint inhibitors in cancer treatment.